Authors

Marta Palomo-Irigoyen, Center for Cooperative Research in Biosciences
Encarni Pérez-Andrés, Center for Cooperative Research in Biosciences
Marta Iruarrizaga-Lejarreta, Center for Cooperative Research in Biosciences
Adrián Barreira-Manrique, Center for Cooperative Research in Biosciences
Miguel Tamayo-Caro, Center for Cooperative Research in Biosciences
Laura Vila-Vecilla, Center for Cooperative Research in Biosciences
Leire Moreno-Cugnon, Center for Cooperative Research in Biosciences
Nagore Beitia, Center for Cooperative Research in Biosciences
Daniela Medrano, Center for Cooperative Research in Biosciences
David Fernández-Ramos, Center for Cooperative Research in Biosciences
Juan José Lozano, Instituto de Salud Carlos III
Satoshi Okawa, University of Luxembourg
José L Lavín, Center for Cooperative Research in Biosciences
Natalia Martín-Martín, Center for Cooperative Research in Biosciences
James D Sutherland, Center for Cooperative Research in Biosciences
Virginia Guitiérez de Juan, Center for Cooperative Research in Biosciences
Monika Gonzalez-Lopez, Center for Cooperative Research in Biosciences
Nuria Macías-Cámara, Center for Cooperative Research in Biosciences
David Mosén-Ansorena, Center for Cooperative Research in Biosciences
Liyam Laraba, Plymouth University
C Oliver Hanemann, Plymouth University
Emanuela Ercolano, Plymouth University
David B Parkinson, Plymouth University
Christopher W. Schultz, BS, Thomas Jefferson UniversityFollow
Marcos J Araúzo-Bravo, Biodonostia Health Research Institute
Alex M Ascensión, Biodonostia Health Research Institute
Daniela Gerovska, Biodonostia Health Research Institute
Haizea Iribar, Instituto Biodonostia
Ander Izeta, Instituto Biodonostia
Peter Pytel, University of Chicago
Philipp Krastel, Novartis Institutes for Biomedical Research
Alessandro Provenzani, University of Trento
Pierfausto Seneci, University of Milan
Ruben D Carrasco, Harvard University
Antonio Del Sol, Center for Cooperative Research in Biosciences
María Luz Martinez-Chantar, Center for Cooperative Research in Biosciences
Rosa Barrio, Center for Cooperative Research in Biosciences
Eduard Serra, Institute for Health Science Research Germans Trias I Pujol
Conxi Lazaro, Catalan Institute of Oncology
Adrienne M Flanagan, University College London
Myriam Gorospe, National Institute on Aging-Intramural Research Program
Nancy Ratner, University of Cincinnati
Ana M Aransay, Center for Cooperative Research in Biosciences
Arkaitz Carracedo, Center for Cooperative Research in Biosciences
Marta Varela-Rey, Center for Cooperative Research in Biosciences
Ashwin Woodhoo, Center for Cooperative Research in Biosciences

Document Type

Article

Publication Date

7-1-2020

Comments

This article is the author’s final published version in The Journal of clinical investigation, Volume 130, Issue 7, July 2020, Pages 3848-3864.

The published version is available at https://doi.org/10.1172/JCI130379. Copyright © Palomo-Irigoyen

Abstract

Cancer cells can develop a strong addiction to discrete molecular regulators, which control the aberrant gene expression programs that drive and maintain the cancer phenotype. Here, we report the identification of the RNA-binding protein HuR/ELAVL1 as a central oncogenic driver for malignant peripheral nerve sheath tumors (MPNSTs), which are highly aggressive sarcomas that originate from cells of the Schwann cell lineage. HuR was found to be highly elevated and bound to a multitude of cancer-associated transcripts in human MPNST samples. Accordingly, genetic and pharmacological inhibition of HuR had potent cytostatic and cytotoxic effects on tumor growth, and strongly suppressed metastatic capacity in vivo. Importantly, we linked the profound tumorigenic function of HuR to its ability to simultaneously regulate multiple essential oncogenic pathways in MPNST cells, including the Wnt/β-catenin, YAP/TAZ, RB/E2F, and BET pathways, which converge on key transcriptional networks. Given the exceptional dependency of MPNST cells on HuR for survival, proliferation, and dissemination, we propose that HuR represents a promising therapeutic target for MPNST treatment.

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

PubMed ID

32315290

Language

English

Included in

Surgery Commons

Share

COinS